Feinstein Institutes Graduates New Cohort of Physician-Scientists
Event summary
- Elmezzi Graduate School of Molecular Medicine held its commencement ceremony on May 21, 2026, graduating two physician-scientists (Alexandra Bekiaridou, MD, PhD, and Russell Hollis, MD, PhD) and awarding honorary degrees to Cori Bargmann, PhD, and Tak W. Mak, PhD.
- The program, supported by The Thomas and Jeanne Elmezzi Foundation, has graduated over 50 physician-scientists since its inception in 1994.
- Graduate research focused on Pulmonary Arterial Hypertension (PAH) and mesenteric ischemia, with potential therapeutic implications.
- Honorary degree recipients recognized for groundbreaking work in neural circuits, cancer genetics, and immunotherapies.
The big picture
The Feinstein Institutes' Elmezzi Graduate School continues to play a critical role in training physician-scientists who can translate lab discoveries into patient therapies. This aligns with broader industry trends emphasizing the need for accelerated biomedical research and the development of next-generation diagnostics and treatments. The program's focus on translational research positions it as a key player in advancing healthcare innovation.
What we're watching
- Research Translation
- How the graduates' findings on PAH and mesenteric ischemia will advance into clinical applications.
- Industry Impact
- Whether the Elmezzi program can sustain its role in producing physician-scientists who bridge lab research and clinical practice.
- Innovation Leadership
- The pace at which Feinstein Institutes can leverage its bioelectronic medicine expertise to drive further breakthroughs.
Related topics